Abstract
Development of a Patient Itinerary for Chimeric Antigen Receptor T Cell (CAR-T) Therapy and Blood and Marrow Transplant (BMT) Recipients and Donors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have